vaccine

Serum Institute launches India’s first indigenous pneumonia vaccine in collab with Gates Foundation

90-year-old Margaret Keenan becomes first human to receive Pfizer COVID-19 vaccine, followed by William Shakespeare

Are people scared of using the COVID-19 vaccine?

India to get 200 million doses of AstraZeneca vaccine by January

Pfizer says COVID-19 vaccine is 90% effective

Russia becomes the first country to grant approval to a second COVID-19 vaccine

Reportedly, Phase 3 which is a large-scale human trial is most likely to begin in November or December and will involve around 30,000 volunteers, of whom the first 5,000 will be natives of Siberia.

“Bharat Biotech should submit safety data before phase 3 clinical trial of “Covaxin”: CDSCO

According to sources, the phase-2 trial of the Covaxin is going on and is left to give the second dose to volunteers at some sites.

Bharat Biotech announces partnership with Washington University School to produce intranasal COVID-19 Vaccine

The vaccine is peculiar as it will be procured via nose, the initial infected area. Researchers claim the nasal route for vaccination has often seen a stronger immune response. 

“By mid-next year there’s a possibility of normalcy even if vaccine comes or not” says Dr Sanjay Rai, AIIMS

As per ICMR serosurvey, 6.4 million adults above the age of 18 yrs have been infected in April-May. Dr Rai said that serosurvey only shows the direction of infection while testing shows the actual number of infections.

250 Moscow residents receive the 1st COVID-19 Vaccine

Gamaleya Research Institute of Epidemiology and Microbiology has developed the first coronavirus vaccine, the Sputnik V COVID vaccine. The vaccine has been approved by the Russian Health Ministry.

Phase three trials for AstraZeneca’s coronavirus vaccine resume

After receiving a green signal from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials, AstraZeneca confirmed to resume. The company has declined to disclose medical information about the 'pause' of the trial.

China’s CanSino defends COVID-19 vaccine candidate

Earlier, scientists said that the success of the company's vaccine might be limited as it is based on a common cold virus that many people have been exposed to. They said existing antibodies against the common cold virus might undermine Ad5-nCoV.

New COVID-19 Vaccine from Oxford to begin human trials in partnership with Serum Institute of India

The U.K based company, SpyBiotech formed out of the University of Oxford in 2017 has devised a new COVID-19 vaccine on an experimental basis which has now begun human trials in Australia in partnership with the Serum Institute of India.

Almost 90% Chinese employees of Sinovac company inoculated with their COVID-19 vaccine

Russian Defence Minister says he feels alright after taking COVID-19 vaccine, did not experience any side-effects